Cargando…

Improving Bone Health in Patients with Metastatic Prostate Cancer with the Use of Algorithm-Based Clinical Practice Tool

Background: The bone health of patients with locally advanced and metastatic prostate cancer is at risk from treatment-related bone density loss and skeletal-related events from metastatic disease in bones. Evidence-based guidelines recommend using denosumab or zoledronic acid at bone metastasis-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahu, Kamal Kant, Johnson, Eric D., Butler, Katerina, Li, Haoran, Boucher, Kenneth M., Gupta, Sumati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778212/ https://www.ncbi.nlm.nih.gov/pubmed/36547269 http://dx.doi.org/10.3390/geriatrics7060133

Ejemplares similares

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma
por: Li, Haoran, et al.
Publicado: (2023)

Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas
por: Li, Haoran, et al.
Publicado: (2023)

A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers
por: Li, Haoran, et al.
Publicado: (2022)

Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0
por: Gebrael, Georges, et al.
Publicado: (2023)

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
por: Johnson, Catherine S., et al.
Publicado: (2023)

Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
por: Inaba, Koji, et al.
Publicado: (2021)

Animal models of bone metastatic prostate cancer
por: Tae, Jong Hyun, et al.
Publicado: (2023)

Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone
por: Dozzo, Annachiara, et al.
Publicado: (2023)

Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
por: Brisset, Jean-Christophe, et al.
Publicado: (2015)

Imaging metastatic bone disease from carcinoma of the prostate
por: Messiou, C, et al.
Publicado: (2009)

Neutrophils are mediators of metastatic prostate cancer progression in bone
por: Costanzo-Garvey, Diane L., et al.
Publicado: (2020)

Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion()
por: Wang, Yugang, et al.
Publicado: (2020)

Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancer
por: Gupta, Nisha, et al.
Publicado: (2016)

Infectious disease in hematopoietic stem cell transplantation
por: Sahu, Kamal Kant
Publicado: (2021)

Trimethyl(triphenylmethoxy)silane
por: Anthal, Sumati, et al.
Publicado: (2012)

Ethyl 2,6-bis(4-chlorophenyl)-4-(4-fluoroanilino)-1-(4-fluorophenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate
por: Anthal, Sumati, et al.
Publicado: (2013)

Ethyl 4-anilino-2,6-bis(4-fluorophenyl)-1-phenyl-1,2,5,6-tetrahydropyridine-3-carboxylate
por: Anthal, Sumati, et al.
Publicado: (2013)

Ethyl 2,6-bis(4-chlorophenyl)-4-(4-methylanilino)-1-(4-methylphenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate
por: Anthal, Sumati, et al.
Publicado: (2013)

Methyl 4-(4-fluoroanilino)-1,2,6-tris(4-fluorophenyl)-1,2,5,6-tetrahydropyridine-3-carboxylate
por: Anthal, Sumati, et al.
Publicado: (2013)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
por: Paiva, Ana E., et al.
Publicado: (2017)

Liver uptake on bone scan for prostate cancer metastatic workup
por: Mukendi, Alain Mwamba
Publicado: (2019)

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets
por: Patel, Amol, et al.
Publicado: (2020)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanoma
por: Liu, Jun S., et al.
Publicado: (2016)

3-(4-Chloroanilino)-5,5-dimethylcyclohex-2-en-1-one
por: Anthal, Sumati, et al.
Publicado: (2012)

5-((Methoxyimino){2-[(2-methylphenoxy)methyl]phenyl}methyl)-N-phenyl-1,3,4-oxadiazol-2-amine
por: Sharma, Devinder K., et al.
Publicado: (2014)

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)
por: Gumbleton, Matthew, et al.
Publicado: (2023)

Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan
por: Agarwal, Krishan Kant, et al.
Publicado: (2016)

Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
por: Owen, Katie L, et al.
Publicado: (2020)

Letter to the Editor Regarding “Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community”
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

2-Amino-7,7-dimethyl-5-oxo-4-(p-tolyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
por: Anthal, Sumati, et al.
Publicado: (2012)

Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines
por: Khochikar, Makarand V.
Publicado: (2007)

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
por: Denis-Bacelar, Ana M, et al.
Publicado: (2018)

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
por: Armstrong, Andrew J., et al.
Publicado: (2019)

Characterization of a rat model of metastatic prostate cancer bone pain
por: De Ciantis, Paolo Donato, et al.
Publicado: (2010)

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015)

Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma
por: Mathur, Pankaj, et al.
Publicado: (2017)

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
por: Josefsson, Andreas, et al.
Publicado: (2018)

COOPERATION AMONG HETEROGENEOUS PROSTATE CANCER CELLS IN THE BONE METASTATIC NICHE
por: Shahriari, Kristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ligbmb5ku8vivettci4m2iab7g